Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-008317
Filing Date
2023-03-16
Accepted
2023-03-16 16:29:43
Documents
1
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167899857206258.html 4  
1 FORM 4 wf-form4_167899857206258.xml 4 3465
  Complete submission text file 0001628280-23-008317.txt   4783
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Munk Natalie (Reporting) CIK: 0001932320 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 23739210